CB1 agonist. Displaces binding of [3H]-SR141716A with an IC50 value of 2.86 μM.
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 321.93. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||3.11 mL||15.53 mL||31.06 mL|
|5 mM||0.62 mL||3.11 mL||6.21 mL|
|10 mM||0.31 mL||1.55 mL||3.11 mL|
|50 mM||0.06 mL||0.31 mL||0.62 mL|
References are publications that support the products' biological activity.
If you know of a relevant reference for Leelamine hydrochloride, please let us know.
View Related Products by Product Action
Keywords: Leelamine hydrochloride, supplier, CB1, agonists, cannabinoids, Receptors, cb1r, Lylamine, hydrochloride, (+)-Dehydroabietylamine, CB1, Receptors, CB1, Receptors, Tocris Bioscience
Citations for Leelamine hydrochloride
Citations are publications that use Tocris products.
Currently there are no citations for Leelamine hydrochloride. Do you know of a great paper that uses Leelamine hydrochloride from Tocris? If so please let us know.
Reviews for Leelamine hydrochloride
There are currently no reviews for this product. Be the first to review Leelamine hydrochloride and earn rewards!
Have you used Leelamine hydrochloride?
Submit a review and receive an Amazon gift card.
$10US/$10CAN/€7/£6 gift card for a review without an image
$25US/$25CAN/€18/£15 gift card for a review with an image
*Offer only valid in the USA / Canada, UK and EuropeSubmit a Review
Literature in this Area
The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.
Schizophrenia is a debilitating psychiatric disorder that affects 1% of the worldwide population. This poster describes the neurobiology of Schizophrenia, as well as highlighting the genetic and environmental factors that play a fundamental role in the etiology of the disease. The current and emerging drug targets are also discussed.